- Home
- GOCO vs GNLX Comparison
GOCO vs GNLX Comparison
Compare GOCO & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GOCO | GNLX |
|---|---|---|
| Founded | 2001 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.3M | 202.4M |
| IPO Year | 2020 | 2023 |
Fundamental Metrics
Financial Performance| Metric | GOCO | GNLX |
|---|---|---|
| Price | $2.44 | $4.20 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $5.00 | ★ $19.75 |
| AVG Volume (30 Days) | 56.1K | ★ 157.5K |
| Earning Date | 11-13-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $738,338,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.56 | N/A |
| 52 Week Low | $2.17 | $1.99 |
| 52 Week High | $21.00 | $8.54 |
Technical Indicators
Market Signals| Indicator | GOCO | GNLX |
|---|---|---|
| Relative Strength Index (RSI) | 31.73 | 35.32 |
| Support Level | $2.50 | $4.00 |
| Resistance Level | $2.79 | $4.37 |
| Average True Range (ATR) | 0.23 | 0.32 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 0.00 | 13.94 |
Price Performance
Historical ComparisonAbout GOCO GoHealth Inc.
GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.